Economic Analysis Supporting Significant Hospitalization
Data illustrate the potential of QUELIMMUNE™️ with cost neutrality starting at 6 days of therapy and a significant reduction in...
Data illustrate the potential of QUELIMMUNE™️ with cost neutrality starting at 6 days of therapy and a significant reduction in...
In a study of Medicare beneficiaries, researchers from Brigham and Women's Hospital found that one year after hospitalization for heart...